Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: Trapping early oligomers of non-expanded ataxin-3

Journal of Molecular Biology

Volumn 353, Issue 3, 2005, Pages 642-654

  Gales, Luís ^a   Cortes, Luísa ^b   Almeida, Carla ^b   Melo, Carlos V ^b   Costa, Maria Do Carmo ^c   Maciel, Patrícia ^c   Clarke, David T ^d   Damas, Ana Margarida ^a   Macedo Ribeiro, Sandra ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d DARESBURY LABORATORY   (United Kingdom)

Author keywords

Amyloid; Neurodegenerative; Polyglutamine; SCA3; Self assembly domain

Indexed keywords

AMYLOID PROTEIN; ATAXIN 3; EPITOPE; OLIGOMER; POLYGLUTAMINE; POLYMER;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CHROMATOGRAPHY; CYTOTOXICITY; ELECTRON MICROSCOPY; MACHADO JOSEPH DISEASE; MOLECULAR WEIGHT; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

CAENORHABDITIS ELEGANS;

EID: 26244434741     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.08.061     Document Type: Article

References (61)

1. C.J. Cummings, and H.Y. Zoghbi Fourteen and counting: unraveling trinucleotide repeat diseases Hum. Mol. Genet. 9 2000 909 916
2. M. Perutz Polar zippers: their role in human disease Protein Sci. 3 1994 1629 1637
3. D.C. Rubinsztein, A. Wyttenbach, and J. Rankin Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? J. Med. Genet. 36 1999 265 270
4. M.F. Perutz, T. Johnson, M. Suzuki, and J.T. Finch Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases Proc. Natl Acad. Sci. USA 91 1994 5355 5358
5. L. Masino, and A. Pastore Glutamine repeats: structural hypotheses and neurodegeneration Biochem. Soc. Trans. 30 2002 548 551
6. S. Chen, V. Berthelier, J.B. Hamilton, B. O'Nuallain, and R. Wetzel Amyloid-like features of polyglutamine aggregates and their assembly kinetics Biochemistry 41 2002 7391 7399
7. E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, and R. Hasenbank Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Cell 90 1997 549 558
8. A.E. Bevivino, and P.J. Loll An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates parallel beta-fibrils Proc. Natl Acad. Sci. USA 98 2001 11955 11960
9. M.A. Poirier, H. Li, J. Macosko, S. Cai, M. Amzel, and C.A. Ross Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization J. Biol. Chem. 277 2002 41032 41037
10. D.P. McGowan, W. van Roon-Mom, H. Holloway, G.P. Bates, L. Mangiarini, and G.J.S. Cooper Amyloid-like inclusions in Huntington's disease Neuroscience 100 2000 677 680
11. B. O'Nuallain, and R. Wetzel Conformational Abs recognizing a generic amyloid fibril epitope Proc. Natl Acad. Sci. USA 99 2002 1485 1490
12. A. Michalik, and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet. 12 2003 R173 R186
13. S. Iuchi, G. Hoffner, P. Verbeke, P. Djian, and H. Green Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine Proc. Natl Acad. Sci. USA 100 2003 2409 2414
14. M. Tanaka, Y. Machida, Y. Nishikawa, T. Akagi, T. Hashikawa, T. Fujisawa, and N. Nukina Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization J. Biol. Chem. 278 2003 34717 34724
15. R. Tycko Progress towards a molecular-level structural understanding of amyloid fibrils Curr. Opin. Struct. Biol. 14 2004 96 103
16. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
17. R. Kayed, Y. Sokolov, B. Edmonds, T.M. McIntire, S.C. Milton, J.E. Hall, and C.G. Glabe Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 279 2004 46363 46366
18. H.L. Paulson, S.S. Das, P.B. Crino, M.K. Perez, S.C. Patel, and D. Gotsdiner Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain Ann. Neurol. 41 1997 453 462
19. B. Burnett, F. Li, and R.N. Pittman The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity Hum. Mol. Genet. 12 2003 3195 3205
20. B.G. Burnett, and R.N. Pittman The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation Proc. Natl Acad. Sci. USA 102 2005 4330 4335
21. Y. Chai, S.S. Berke, R.E. Cohen, and H.L. Paulson Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways J. Biol. Chem. 279 2004 3605 3611
22. J.M. Warrick, L.M. Morabito, J. Bilen, B. Gordesky-Gold, L.Z. Faust, H.L. Paulson, and N.M. Bonini Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism Mol. Cell. 18 2005 37 48
23. L. Masino, V. Musi, R.P. Menon, P. Fusi, G. Kelly, and T.A. Frenkiel Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail FEBS Letters 549 2003 21 25
24. H. Scheel, S. Tomiuk, and K. Hofmann Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics Hum. Mol. Genet. 12 2003 2845 2852
25. J. Goto, M. Watanabe, Y. Ichikawa, S.B. Yee, N. Ihara, and K. Endo Machado-Joseph disease gene products carrying different carboxyl termini Neurosci. Res. 28 1997 373 377
26. P. Maciel, C. Gaspar, A.L. DeStefano, I. Silveira, P. Coutinho, and J. Radvany Correlation between CAG repeat length and clinical features in Machado-Joseph disease Am. J. Hum. Genet. 57 1995 54 61
27. E. Shehi, P. Fusi, F. Secundo, S. Pozzuolo, A. Bairati, and P. Tortora Temperature-dependent, irreversible formation of amyloid fibrils by a soluble human ataxin-3 carrying a moderately expanded polyglutamine stretch (Q36) Biochemistry 42 2003 14626 14632
28. S. Marchal, E. Shehi, M.C. Harricane, P. Fusi, F. Heitz, P. Tortora, and R. Lange Structural instability and fibrillar aggregation of non-expanded human ataxin-3 revealed under high pressure and temperature J. Biol. Chem. 278 2003 31554 31563
29. M.K. Chow, H.L. Paulson, and S.P. Bottomley Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease J. Mol. Biol. 335 2004 333 341
30. Y. Chai, L. Wu, D. Griffin James, and L. Paulson Henry The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease J. Biol. Chem. 276 2001 44889 44897
31. L. Masino, G. Nicastro, R.P. Menon, F.D. Piaz, L. Calder, and A. Pastore Characterization of the structure and the amyloidogenic properties of the josephin domain of the polyglutamine-containing protein ataxin-3 J. Mol. Biol. 344 2004 1021 1035
32. I. Cardoso, C.S. Goldsbury, S.A. Muller, V. Olivieri, S. Wirtz, and A.M. Damas Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils J. Mol. Biol. 317 2002 683 695
33. J.C. Rochet, K.A. Conway, and P.T. Lansbury Jr Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein Biochemistry 39 2000 10619 10626
34. S. Chen, F.A. Ferrone, and R. Wetzel Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation Proc. Natl Acad. Sci. USA 99 2002 11884 11889
35. S. Chen, V. Berthelier, W. Yang, and R. Wetzel Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity J. Mol. Biol. 311 2001 173 182
36. M.K. Chow, A.M. Ellisdon, L.D. Cabrita, and S.P. Bottomley Polyglutamine expansion in ataxin-3 does not affect protein stability: Implications for misfolding and disease J. Biol. Chem. 279 2004 47643 47651
37. A. Demuro, E. Mina, R. Kayed, S.C. Milton, I. Parker, and C.G. Glabe Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers J. Biol. Chem. 280 2005 17294 17300
38. M. Stefani, and C.M. Dobson Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699
39. K. Stott, J.M. Blackburn, P.J.G. Butler, and M. Perutz Incorporation of glutamine repeats makes protein oligomerize - implications for neurodegenerative diseases Proc. Natl Acad. Sci. USA 92 1995 6509 6513
40. Y.W. Chen, K. Stott, and M.F. Perutz Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat Proc. Natl Acad. Sci. USA 96 1999 1257 1261
41. J.G. Duncan, R.J. Carbajo, K. Stott, and D. Neuhaus Solution studies of chymotrypsin inhibitor-2 glutamine insertion mutants show no interglutamine interactions Biochem. Biophys. Res. Commun. 280 2001 855 860
42. M.J. Bennett, and D. Eisenberg The evolving role of 3D domain swapping in proteins Structure 12 2004 1339 1341
43. M. Jaskolski 3D domain swapping, protein oligomerization, and amyloid formation Acta Biochim. Pol. 48 2001 807 827
44. E.N. Burright, J.D. Davidson, L.A. Duvick, B. Koshy, H.Y. Zoghbi, and H.T. Orr Identification of a self-association region within the SCA1 gene product, ataxin-1 Hum. Mol. Genet. 6 1997 513 518
45. C. de Chiara, R.P. Menon, S. Adinolfi, J. de Boer, E. Ktistaki, and G. Kelly The AXH domain adopts alternative folds the solution structure of HBP1 AXH Structure 13 2005 743 753
46. P. Fernandez-Funez, M.L. Nino-Rosales, B. de Gouyon, W.C. She, J.M. Luchak, and P. Martinez Identification of genes that modify ataxin-1-induced neurodegeneration Nature 408 2000 101 106
47. X. Fan, P. Dion, J. Laganiere, B. Brais, and G.A. Rouleau Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death Hum. Mol. Genet 10 2001 2341 2351
48. H. Paulson Polyglutamine neurodegeneration: minding your Ps and Qs Nature Med. 9 2003 825 826
49. S. Chen, A. Ferrone Frank, and R. Wetzel Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation Proc. Natl Acad. Sci. USA 99 2002 11884 11889
50. J.D. Harper, and P.T. Lansbury Jr Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
51. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, and J. Zurdo Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
52. D.M. Walsh, and D.J. Selkoe Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Letters 11 2004 213 228
53. G. Schaffar, P. Breuer, R. Boteva, C. Behrends, N. Tzvetkov, and N. Strippel Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation Mol. Cell. 15 2004 95 105
54. J. Kazlauskaite, A. Young, C.E. Gardner, J.V. Macpherson, C. Venien-Bryan, and T.J. Pinheiro An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells Biochem. Biophys. Res. Commun. 328 2005 292 305
55. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
56. H. Fujigasaki, T. Uchihara, S. Koyano, K. Iwabuchi, S. Yagishita, and T. Makifuchi Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains Expt. Neurol. 165 2000 248 256
57. H. Fujigasaki, T. Uchihara, J. Takahashi, H. Matsushita, A. Nakamura, and S. Koyano Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies J. Neurol. Neurosurg. Psychiatry 71 2001 518 520
58. A.P. Lieberman, J.Q. Trojanowski, D.G. Leonard, K.L. Chen, J.L. Barnett, and J.B. Leverenz Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease Ann. Neurol. 46 1999 271 273
59. L. Gales, I. Cardoso, B. Fayard, A. Quintanilha, M.J. Saraiva, and A.M. Damas X-ray absorption spectroscopy reveals a substantial increase of sulfur oxidation in transthyretin (TTR) upon fibrillization J. Biol. Chem. 278 2003 11654 11660
60. O. Poirot, E. O'Toole, and C. Notredame Tcoffee@igs: a web server for computing, evaluating and combining multiple sequence alignments Nucl. Acids Res. 31 2003 3503 3506
61. G.J. Barton ALSCRIPT: a tool to format multiple sequence alignments Protein Eng. 6 1993 37 40